FindTrial
Sign In

To study effect of Vitamin D supplementation in asthma patients

Comparison of Budesonide plus formoterol and vitamin D versus Budesonide plus formoterol in Asthma at tertiary care hospital A Prospective Open label Randomized controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036165
Enrollment
264
Registered
2021-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system

Interventions

Intervention1: Vitamin D supplementation and Budesonide plus Formoterol: Vitamin D supplementation 60,000 IU/ week, orally capsule, for 8 weeks with Budesonide plus Formoterol treatment in asthma pati

Sponsors

Dr Preeti Navik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age Group more then 18 years Patients of mild and moderate asthma taking Budesonide plus Formoterol treatment

Exclusion criteria

Exclusion criteria: Patients already taking vitamin D supplements Inability to perform adequate spirometry Patients of Asthma COPD overlap syndrome ACOS Patients with renal stones Patients taking liquid paraffin

Design outcomes

Primary

MeasureTime frame
To compare the response of changes in spirometry FEV1 Forced expiratory volume per second ,FEV/FVC , PEFR Peak expiratory flow rateTimepoint: To compare the response of changes in spirometry FEV1 Forced expiratory volume per second ,FEV/FVC , PEFR Peak expiratory flow rate at baseline, at the end of 4 weeks, at the end of 8 weeks—

Secondary

MeasureTime frame
To compare the frequency of episodes of asthma To compare the asthma related quality of life score Timepoint: study will be conducted from july 2021 to oct 2022—

Countries

India

Contacts

Public ContactDr Preeti Navik

Government Medical College Bhavnagar

drbhargavpurohit@gmail.com9725024978

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026